Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas
- PMID: 8117621
Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas
Abstract
To assess the effects of transforming growth factor alpha (TGF-alpha) on mammalian skin in vivo, we have targeted its expression to the epidermis of transgenic mice using a vector based on the human K1 (HK1) gene. Neonatal mice expressing the HK1.TGF-alpha transgene were often smaller than normal littermates and had precocious eyelid opening and wrinkled, scaly skin with diffuse alopecia. Juvenile transgenic mouse epidermis was uniformly hyperkeratotic, but this pattern was generally less pronounced in adult transgenic mice unless they expressed high levels of the HK1.TGF-alpha transgene. Spontaneous, squamous papillomas occurred at sites of wounding in adult mice expressing high levels of HK1.TGF-alpha; however, most were prone to regression. Immunoreactive TGF-alpha was 2-6 times higher in the epidermis of these HK1.TGF-alpha lines. Immunoreactive epidermal growth factor receptor had a normal pattern of expression in nonphenotypic adult epidermis, but a marked reduction in the receptor population was detected in hyperplastic newborn epidermis and phenotypic adult epidermis. Autoradiographic localization of 125I-epidermal growth factor showed a similar pattern of distribution, suggesting that the sites of increased TGF-alpha expression induced epidermal growth factor receptor down-regulation. These data demonstrate the in vivo effect of deregulated TGF-alpha expression on epidermal proliferation and differentiation and suggest a potential role for TGF-alpha in carcinogenesis and other hyperproliferative epidermal disorders.
Similar articles
-
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.Cancer Res. 1996 Oct 1;56(19):4413-23. Cancer Res. 1996. PMID: 8813135
-
TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.Oncogene. 1995 Jan 19;10(2):279-89. Oncogene. 1995. PMID: 7530825
-
Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.Mol Carcinog. 2000 Mar;27(3):200-9. Mol Carcinog. 2000. PMID: 10708482
-
Transgenic models of skin diseases.Arch Dermatol. 1993 Nov;129(11):1430-6. Arch Dermatol. 1993. PMID: 7694550 Review.
-
Multistage epidermal carcinogenesis in transgenic mice: cooperativity and paradox.J Investig Dermatol Symp Proc. 1996 Apr;1(2):162-76. J Investig Dermatol Symp Proc. 1996. PMID: 9627712 Review.
Cited by
-
EGFR-ras-raf signaling in epidermal stem cells: roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers.Int J Mol Sci. 2013 Sep 25;14(10):19361-84. doi: 10.3390/ijms141019361. Int J Mol Sci. 2013. PMID: 24071938 Free PMC article. Review.
-
The molecular basis for inherited bullous diseases.J Mol Med (Berl). 1996 Feb;74(2):59-70. doi: 10.1007/BF00196781. J Mol Med (Berl). 1996. PMID: 8820401 Review.
-
Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.J Cell Biol. 1996 Oct;135(1):227-39. doi: 10.1083/jcb.135.1.227. J Cell Biol. 1996. PMID: 8858176 Free PMC article.
-
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2386-91. doi: 10.1073/pnas.94.6.2386. Proc Natl Acad Sci U S A. 1997. PMID: 9122204 Free PMC article.
-
Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.Br J Cancer. 2013 Jul 23;109(2):482-92. doi: 10.1038/bjc.2013.321. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799848 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous